Certainly, both of the centenarian donors in our study were negative for the APOE-ε4 variant (Text S1), which is the most significant established genetic risk factor for late-onset sporadic AD [20]–[23], and which is also associated with increased risk of early mortality [24], [25]. This evidence concerns the gene APOE and Alzheimer disease.